PF-07104091
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for PF-07104091, covering 2024-04-08 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: PF-07104091 as a Single Agent and in Combination Therapy [Phase 2]